
Abbott Labs (ABT) Stock Forecast & Price Target
Abbott Labs (ABT) Analyst Ratings
Bulls say
Abbott Laboratories is expected to see continued growth in their Diabetes Care division due to the demand for continuous glucose monitors (CGMs), potential expansion in the market, and planned product launches and manufacturing expansion. The company also has a strong Medical Device and Diagnostics portfolio, with double-digit EPS growth and a focus on high-growth areas such as electrophysiology and cancer diagnostics. Strategic investments and a diverse board and management team are expected to drive future growth, but there are potential risks to their price target and rating.
Bears say
Abbott Laboratories is facing some challenges in their Nutrition and Established Pharmaceuticals segments, with declining sales and pricing actions impacting their performance. While the company has a strong commitment to investing in growth and increasing shareholder value, they are also subject to strict product requirements and potential product recalls. Additionally, ABT is focused on promoting diversity and sustainability, which could further impact their financial performance in the short term.
This aggregate rating is based on analysts' research of Abbott Labs and is not a guaranteed prediction by Public.com or investment advice.
Abbott Labs (ABT) Analyst Forecast & Price Prediction
Start investing in Abbott Labs (ABT)
Order type
Buy in
Order amount
Est. shares
0 shares